Thematische Bibliographien / Southern California Permanente Medical Group

Auswahl der wissenschaftlichen Literatur zum Thema „Southern California Permanente Medical Group“

Autor: Grafiati

Veröffentlicht am 27. Juli 2024

Zuletzt aktualisiert am 29. Juli 2024

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Southern California Permanente Medical Group" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Zeitschriftenartikel zum Thema "Southern California Permanente Medical Group"

Munro, Malcolm. „Acute Uterine Bleeding Unrelated to Pregnancy: A Southern California Permanente Medical Group Practice Guideline“. Permanente Journal 17, Nr. 3 (01.08.2013): 43–56. http://dx.doi.org/10.7812/tpp/13-018.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Ghochani, Mariam, Atieh Hajianpour, Abbas Padeganeh, Casey Brewer, Farzad Nooraie, Rezvan Habibian, Mike Moradian und Ruan Ramjit. „Cytogenomic microarray analysis as a first-tier clinical diagnostic test: Kaiser Permanente, Southern California Permanente Medical Group experience“. Molecular Genetics and Metabolism 132 (April 2021): S287. http://dx.doi.org/10.1016/s1096-7192(21)00529-1.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Tran, Hung. „QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT“. Neuro-Oncology 22, Supplement_3 (01.12.2020): iii441. http://dx.doi.org/10.1093/neuonc/noaa222.710.

Der volle Inhalt der Quelle

Annotation:

Abstract KEY MESSAGE Standardization of care for subspecialty patients require centralization and support across multi-disciplinary groups within the Kaiser Permanente medical group, which is a large health maintenance organization (HMO) in the United States. BACKGROUND Prior to the development of a Pediatric Neuro-Oncology program, Southern California Kaiser Permanente pediatric neuro-oncology patients were routinely referred to respective regional academic centers for consultation. The process was not standard across the region, resulting in additional costs and differences in treatment recommendations, potentially affecting outcomes. METHODS A Pediatric Neuro-Oncology program was established, July 2017, based at the Kaiser Permanente Los Angeles Medical Center (LAMC), consisting of pediatric neuro-oncology, pediatric neurosurgery, pediatric neuro-radiology, pediatric radiation oncology, and pediatric neuro-oncology case management. RESULTS A Pediatric Neuro-Oncology tumor board was established to meet on a bi-monthly basis. Pediatric neuro-oncology patients across the Southern California now have their magnetic resonance imaging (MRI) reviewed by the same pediatric neuro radiologists. Neuropathology is standardized and sent to Children’s Hospital Los Angeles and reviewed at the molecular neuropathology tumor board attended by the pediatric neuro-oncologist. Cases discussions regarding the patients include the regional pediatric neurosurgeons, the pediatric radiation oncologists, and the pediatric neuro-oncologist, and treatment plans are recommended and recorded by the case manager. CONCLUSIONS Centralization of care has allowed for more consistent and standard care across the Southern California Region, but requires support from multi-disciplinary groups.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Andryjowicz, E. „Implementation and Methodology for Expanding Minimally Invasive Surgery (MIS) for Hysterectomy within Southern California Permanente Medical Group“. Journal of Minimally Invasive Gynecology 18, Nr. 6 (November 2011): S32. http://dx.doi.org/10.1016/j.jmig.2011.08.113.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Cohen, David S., Jane E. Tongson-Ignacio, Christopher M. Lolachi, Vanessa S. Ghaderi, Babak Jahan-Parwar und Lester D. R. Thompson. „Rethinking Malignancy Risk in Indeterminate Thyroid Nodules with Positive Molecular Studies: Southern California Permanente Experience“. Otolaryngology–Head and Neck Surgery 161, Nr. 3 (23.04.2019): 419–23. http://dx.doi.org/10.1177/0194599819842859.

Der volle Inhalt der Quelle

Annotation:

Objectives To recognize that thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS; Bethesda III) have different risks of malignancy based on genetic mutation and to consider molecular testing of nodules with AUS/FLUS to help avoid unnecessary morbidity or cost. Study Design Retrospective cohort study. Setting Multiple locations within Southern California Permanente Medical Group. Subjects and Methods Patients included those with indeterminate thyroid nodules and AUS/FLUS on 2 separate fine-needle aspirations with positive ThyGenX testing from 2014 to 2017 who underwent thyroid surgery. Patients were classified as having benign or malignant disease. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features was considered benign. Results A total of 231 patients had repeat AUS/FLUS with positive molecular testing and surgery. The most frequent type of malignancy was papillary carcinoma, followed by follicular carcinoma. The overall prevalence of malignancy in nodules with mutations was 74.0%, although there was considerable variation: BRAF = 100%, RET = 100%, PAX8-PPARγ = 84.6%, HRAS = 70.7%, NRAS = 63.4%, and KRAS = 33%—a statistically significant finding ( P < .001). Conclusions Not all molecular mutations in thyroid nodules with AUS/FLUS have a high risk of malignancy. Of note, patients with BRAF and RET mutations in our population had a 100% risk of malignancy. Patients with PAX, HRAS, or NRAS mutations had a high risk of malignancy, while patients with KRAS mutations had a lower risk of malignancy. Further studies are needed to determine if the presence of certain molecular mutations can help personalize care and aid in the decision for thyroid surgery.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Jordan, Jennifer Lyn, und Robert Michael Cooper. „Prevalence of overweight and obesity in a population of childhood leukemia patients and survivors.“ Journal of Clinical Oncology 30, Nr. 34_suppl (01.12.2012): 324. http://dx.doi.org/10.1200/jco.2012.30.34_suppl.324.

Der volle Inhalt der Quelle

Annotation:

324 Background: Overweight and obesity (BMI>95 percentile) in the pediatric population has become a prominent problem. The prevalence of pediatric obesity has increased from 5% in 1976-1980 to 17% among children and adolescents in 2007-2008. The presence of obesity in survivors of certain childhood cancers has been identified as a late effect of therapy, especially in survivors of ALL and brain tumors. Obesity prevalence following treatment for ALL ranges from 11-57%. The long-term health consequences of obesity include diabetes mellitus, hypertension, cardiovascular disease, metabolic syndrome and certain cancers. Kaiser Permanente (KP) tracks pediatric BMI as part of routine health maintenance. There is an initiative to promote Healthy Eating and Active Living (HEAL) and reduce childhood obesity. As part of this initiative the HEAL clinic provides a multi-disciplinary weight management program for the general adolescent population at KP Los Angeles Medical Center (LAMC). Methods: A chart review was conducted using the electronic medical record system at LAMC. 99 records, 22 current patients and 77 survivors of ALL, were identified and reviewed for Body Mass Index (BMI) and compared to the general pediatric population of KP in Southern California. Results: See Table. 57 leukemia patients and survivors were identified as overweight or obese, which is a 57.5% prevalence rate. This is significantly higher than the rate of pediatric overweight and obesity of 37.1% in the KP Southern California general population. Conclusions: The use of an electronic medical record system confirms a higher prevalence of overweight and obesity in the ALL patients and survivors at KP LAMC than the general pediatric population in Southern California. The intervention piloted by the HEAL clinic has been adapted to treat this group of overweight and obese cancer patients and survivors. [Table: see text]

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Chang, Jason, Joseph E. Ahn, Nicholas Landsman, Katherine Rhee, Linda Chun und Kaushal Kevin Patel. „Efficacy of Contemporary Medical Management for Asymptomatic Carotid Artery Stenosis“. American Surgeon 79, Nr. 10 (Oktober 2013): 987–91. http://dx.doi.org/10.1177/000313481307901006.

Der volle Inhalt der Quelle

Annotation:

In the Asymptomatic Carotid Artery Stenosis trial (1995), medical management was defined as aspirin in addition to adequate control of comorbidities. Since then, medical management of asymptomatic carotid artery stenosis (CAS) has progressed to include broader use of statins. Our purpose was to review the effect of contemporary medical management on stroke prevention. A retrospective review of the Kaiser Permanente, Southern California medical group database was performed. All patients with a diagnosis of asymptomatic CAS by International Classification of Diseases, 9th Revision codes from 2007 to 2011 were identified. Intervention for stroke prevention was the criteria for exclusion. Medications used were evaluated as was the rate of stroke. Asymptomatic CAS was noted in 7255 patients. Of these, 158 (2.2%) sustained a stroke within a mean follow-up of 37 months. Patients who were taking a statin had a statistically significant lower risk of stroke (1.6 vs 3.9%). The data support that contemporary medical management of asymptomatic CAS has decreased the incidence of stroke in comparison to previously published data. The use of statins was protective against the development of stroke. Future prospective randomized trials are needed to evaluate the efficacy of carotid intervention versus current medical management.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Battaglia, Alex, Raoul Burchette, Jacob Hussman, Matthew A. Silver, Peter Martin und Paul Bernstein. „Comparison of Medical Therapy Alone to Medical Therapy with Surgical Treatment of Peritonsillar Abscess“. Otolaryngology–Head and Neck Surgery 158, Nr. 2 (07.11.2017): 280–86. http://dx.doi.org/10.1177/0194599817739277.

Der volle Inhalt der Quelle

Annotation:

Objective This study was performed to determine whether the efficacy and safety of medical management of uncomplicated peritonsillar abscess (PTA) presenting in the emergency department is equivalent to medical plus surgical therapy. Study Design Case series with chart review. Setting Southern California Permanente Medical Group (SCPMG). Subjects and Methods Upon successful completion of a prospective study comparing medical treatment (MT) to surgical treatment (ST) of PTA in 2008, MT was adopted by 12 SCPMG centers while 7 centers continued standard surgical drainage. Clinical outcomes are now reviewed on a random sampling of 211 patients with PTA treated with MT and 96 patients treated with ST between 2008 and 2013 at the respective medical centers. Patients were treated with intravenous (IV) fluids, weight-appropriate IV ceftriaxone, clindamycin, and dexamethasone, and then discharged on clindamycin × 10 days (MT). Patients in the ST group received MT but also surgical drainage. Primary end points were complication rates and failure rates. Results MT and ST resulted in no significant difference in treatment success or complications. However, patients in the MT group obtained significantly less liquid opioid prescriptions (MT, 30.8 ± 5.65; ST, 77.75 ± 13.41; P < .0001), reported fewer sore days (MT, 4.48 ± 0.27; ST, 5.77 ± 0.49; P = .0004), and required less days off from work (MT, 3.4 ± 0.44; ST, 4.9 ± 0.82; P = .044). Conclusions Compared to ST, MT appears to be equally safe and efficacious, with less pain, opioid use, and days off work, especially if patients with PTA present without trismus. MT for PTAs reduces the possibility of surgical complications, as well as the cost and inconvenience associated with ST.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Bell, Elizabeth, Robert Michael Cooper und Lisa Mueller. „Using the electronic medical record to identify and follow survivors of pediatric malignancies.“ Journal of Clinical Oncology 30, Nr. 34_suppl (01.12.2012): 302. http://dx.doi.org/10.1200/jco.2012.30.34_suppl.302.

Der volle Inhalt der Quelle

Annotation:

302 Background: There are currently more than 328,000 survivors of pediatric malignancies in the United States (NCI, The Childhood Cancer Survivor Study: An Overview, http://www.cancer.gov/cancertopics/coping/ccss . 6/6/2012). These survivors are at risk for significant late effects from their cancer treatments (Childhood Cancer Survivors Study (Oeffinger, et al, NEJM 2006)). The Kaiser Permanente health care system has good insurance retention of patients treated for pediatric malignancies. Kaiser also uses an electronic medical record, which improves our ability to identify survivors and follow them over time to identify and manage late effects of cancer treatment. The Children’s Oncology Group (COG) has released a summary of cancer treatment form and specific guidelines for follow-up based on patients’ treatment. Methods: In 2010, we queried the Kaiser Permanente Southern California Cancer Registry for all patients who were diagnosed with a malignancy under the age of 18 from 1980 to 2009. This was cross-referenced with list of current Kaiser members as of 2010. We created a database of the current members and their diagnosis, treatment center, age at diagnosis, date of diagnosis, current age, years of survivorship, and sex. We divided the patients into priority groups: (1) more than 5 years from diagnosis and over age 18, (2) more than 5 years from diagnosis and less than age 18, and (3) less than 5 years from diagnosis. We began to prepare summaries of cancer treatment for the groups using the COG form. Results: We identified 1,267 survivors of pediatric malignancies who were Kaiser members in 2010. 54% are still Kaiser members 10 years after diagnosis. There were 611 in Group 1, 293 in Group 2, and 363 in Group 3. We have prepared summaries of cancer treatment including late effects for 400 of the survivors, 360 from Group 1, and 40 from Group 2. Conclusions: The combination of an electronic medical record and insurance retention allows us to identify and track survivors of pediatric malignancies into adulthood. With completed summaries of cancer treatment we will be able to quickly identify at-risk populations for monitoring and potential interventions.

APA, Harvard, Vancouver, ISO und andere Zitierweisen

McDonough, Paul G., und Sylvain Fribourg. „Leuprolide Depot Before Myomectomy**This is a personal communication of the author’s and not to be construed as representing in any way either Kaiser Permanente or the Southern California Permanente Medical Group.“ Fertility and Sterility 53, Nr. 4 (April 1990): 754. http://dx.doi.org/10.1016/s0015-0282(16)53480-3.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Mehr Quellen

Bücher zum Thema "Southern California Permanente Medical Group"

SCPMG... the First Fifty Years - History of the Southern California Permanente Medical Group 1953 - 2003. SCPMG, 2003.

Den vollen Inhalt der Quelle finden

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Buchteile zum Thema "Southern California Permanente Medical Group"

Mohrman, Susan Albers, und Michael Kanter. „Creating High-Value, Sustainable Healthcare: The Technical and Social Elements of Evidence-Based Medicine at the Southern California Permanente Medical Group“. In Reconfiguring the Ecosystem for Sustainable Healthcare, 133–63. Emerald Group Publishing Limited, 2014. http://dx.doi.org/10.1108/s2045-060520140000004009.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Konferenzberichte zum Thema "Southern California Permanente Medical Group"

Prevots, DR, D. Strickland, L. Jackson, P. Shaw, YR Shea, R. Montes de Oca und KN Olivier. „Prevalence of Nontuberculous Mycobacterial Disease, Kaiser Permanente Southern California, and Group Health Cooperative, Seattle, Washington, 1991-2006.“ In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5266.

Der volle Inhalt der Quelle

APA, Harvard, Vancouver, ISO und andere Zitierweisen

Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!